Nasdaq Listing Council affirms delisting of CERo Therapeutics securities

CERO THERAPEUTICS HOLDINGS, INC.

On Jan 29, 2026, the Nasdaq Listing and Hearing Review Council upheld the Panel's Oct 29, 2025 decision to delist CERo common stock and warrants.
Delisting and trading suspension originally effective Oct 31, 2025; the Council's affirmance makes the delisting final.
Common stock ticker CERO and warrants ticker CEROW will no longer trade on Nasdaq.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.